ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Matthew E. Berginski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4798-3273; OpenAlex author ID A5090261482. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. Co-author DOI 10.7717/peerj.17797 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matthew B. Lipner · 1 shared paper, 2024 · strength 0.20
- Paper Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. DOI 10.7717/peerj.17797 ↗
Gary L. Johnson · 1 shared paper, 2024 · strength 0.20
- Paper Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. DOI 10.7717/peerj.17797 ↗
Naim U. Rashid · 1 shared paper, 2024 · strength 0.20
- Paper Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. DOI 10.7717/peerj.17797 ↗
Shawn M. Gomez · 1 shared paper, 2024 · strength 0.20
- Paper Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. DOI 10.7717/peerj.17797 ↗
Jen Jen Yeh · 1 shared paper, 2024 · strength 0.20
- Paper Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. DOI 10.7717/peerj.17797 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.